Lv1
20 积分 2022-02-16 加入
How I treat HLH-like toxicities after immune effector cell therapy
8天前
已关闭
Invasive fungal infection in patients receiving chemotherapy for hematological malignancy: a multicenter, prospective, observational study in China
12天前
已完结
Multi-centers experience using therapeutic plasma exchange for corticosteroid/tocilizumab-refractory cytokine release syndrome following CAR-T therapy
1个月前
已完结
How I Treat HLH-Like Toxicities Following Immune Effector Cell Therapy
3个月前
已关闭
Clinical and Cytokine Features of Immune Effector Cell-Associated Hemophagocytic Lymphohistiocytosis-Like Syndrome
4个月前
已完结
Daratumumab for eradication of minimal residual disease in high-risk advanced relapse of T-cell/CD19/CD22-negative acute lymphoblastic leukemia
4个月前
已完结
Triplet Therapies in Chronic Lymphocytic Leukemia
4个月前
已完结
Cytokine release syndrome and neurotoxicity following CAR T-cell therapy for hematologic malignancies
5个月前
已完结
The role of cytokines in cytokine release syndrome (CRS) after CAR T cell therapy
5个月前
已关闭
Lactate modulates CD4+ T-cell polarization and induces an immunosuppressive environment, which sustains prostate carcinoma progression via TLR8/miR21 axis
6个月前
已完结
皖公网安备34019202002308
